Dr. Choi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
retired
Stony Brook, NY 11794
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1982 - 1983
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1979 - 1982- Brigham and Women's HospitalInternship, Internal Medicine, 1978 - 1979
Harvard Medical SchoolClass of 1978
Certifications & Licensure
NH State Medical License 2024 - 2026
NY State Medical License 2012 - 2024
MO State Medical License 2010 - 2016
GA State Medical License 2008 - 2014
PA State Medical License 2005 - 2008- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow American Association for the Advancement of Science, 2005
- Fellow College of Physicians of Philadelphia, 2004
- Christopher Reeve Research Medal Christopher and Dana Reeve Foundation, 1998
- Join now to see all
Publications & Presentations
PubMed
- 146 citationsExcitotoxicity, free radicals, and cell membrane changes.Laura L. Dugan, Dennis W. Choi
Annals of Neurology. 1994-05-13 - 326 citationsGlutamate receptors and the induction of excitotoxic neuronal death.Dennis W. Choi
Progress in Brain Research. 1994-01-01 - 810 citationsPharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonistsDennis W. Choi, Jae-Young Koh, Stephen Peters
The Journal of Neuroscience. 1988-01-01
Press Mentions
GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)September 19th, 2022- Genes from over 5,000 Stroke Patients Hint at Surprising TreatmentMay 8th, 2022
- Calming Overexcited Neurons May Protect the Brain After a StrokeApril 26th, 2022
- Join now to see all
Grant Support
- Zinc And Ischemic Brain InjuryNational Institute Of Neurological Disorders And Stroke2000–2002
- Excitotoxic Cell Death Of ES Derived Neural Lineage CellsNational Institute Of Neurological Disorders And Stroke2000–2002
- Zinc NeurotoxicityNational Institute Of Neurological Disorders And Stroke2001
- ES Cell Transplantation After Spinal Cord InjuryNational Institute Of Neurological Disorders And Stroke2000–2001
- Cell-Cell Interaction And Hypoxic Brain InjuryNational Institute Of Neurological Disorders And Stroke2000
- Nervous System Development And InjuryNational Institute Of Neurological Disorders And Stroke1997–2000
- Glutamate Neurotoxicity In VitroNational Institute Of Neurological Disorders And Stroke1995–1999
- Contribution Of AMPA/KA Receptor To Hypoxic Neuronal Injury In VitroNational Institute Of Neurological Disorders And Stroke1995–1999
- Cell Cell Interaction And Hypoxic Brain InjuryNational Institute Of Neurological Disorders And Stroke1995–1999
- 21ST Princeton Conference On Cerebrovascular DiseaseNational Institute Of Neurological Disorders And Stroke1997
- Basic Neuroscience Training For Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1993–1996
- Glutamate Neurotoxicity In Cortical Cell CultureNational Institute Of Neurological Disorders And Stroke1991–1994
- Basic Clinical Neuroscience TrainingNational Institute Of Neurological Disorders And Stroke1992
- Pharmacologic Reduction Of Hypoxic Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1991–1992
- Pharmacologic Reduction Of Hypoxic Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1988–1990
- Glutamate Chemosensitivity Of Cortical NeuronsNational Institute Of Neurological Disorders And Stroke1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
